Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

May 5, 2014

Cancer Vaccines in the Omics Era

New technologies and approaches are leading to new breakthroughs.

Cancer Vaccines in the Omics Era

Tumor-specific antigens released from dying tumor cells killed in an immunologically relevant manner are phagocytized by dendritic cells and presented to T cells, which become activated against a broader array of targets. [NIH Medical Arts]

  • Until a few decades ago, cancer was mostly viewed as a genetic condition in which a single mutated cell clone survived and gave rise ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »